학술논문
Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis
Document Type
Article
Author
Source
In: Pediatric Allergy and Immunology . (Pediatric Allergy and Immunology, July 2023, 34(7))
Subject
Language
English
ISSN
13993038
09056157
09056157